NYSEMKT: CANF
Can Fite Biopharma Ltd Stock Ownership - Who owns Can Fite Biopharma?

Insider buying vs selling

Have Can Fite Biopharma Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CANF insiders and whales buy or sell their stock.

CANF Shareholders

What type of owners hold Can Fite Biopharma Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Rhumbline Advisers10.77%281,881$862.56kInstitution
Jane Street Group LLC7.83%205,004$627.31kInstitution
Osaic Holdings Inc1.37%36,000$110.16kInstitution
Ubs Group Ag0.80%20,942$64.08kInstitution
Xtx Topco Ltd0.71%18,686$57.18kInstitution
Bogart Wealth LLC0.57%15,045$46.04kInstitution
Two Sigma Securities LLC0.46%12,088$36.99kInstitution
Fifth Third Bancorp0.11%3,000$9.18kInstitution
Wells Fargo Company0.10%2,500$7.65kInstitution
Costello Asset Management Inc0.04%1,000$3.06kInstitution

1 of 2

CANF vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CANF22.78%0.00%
AZTR1.39%98.08%
GLMD3.37%3.23%
SLXN0.28%99.72%Net BuyingNet Selling
REVB12.55%87.45%Net BuyingNet Selling

Can Fite Biopharma Stock Ownership FAQ

Who owns Can Fite Biopharma?

Can Fite Biopharma (NYSEMKT: CANF) is owned by 22.78% institutional shareholders, 0.00% Can Fite Biopharma insiders, and 77.21% retail investors. Pnina Fishman is the largest individual Can Fite Biopharma shareholder, owning 88.00 shares representing 0.00% of the company. Pnina Fishman's Can Fite Biopharma shares are currently valued at $266.64.

If you're new to stock investing, here's how to buy Can Fite Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.